Quantcast

Peoria Standard

Sunday, December 22, 2024

FDA considers banning phenylephrine due to ineffectiveness

Webp p9u5g7dw8scirj7e7wqlhl6erjt8

Lena Nilsson, Vice President of Clinical Operations | OSF HealthCare

Lena Nilsson, Vice President of Clinical Operations | OSF HealthCare

Recently, the U.S. Food and Drug Administration (FDA) determined that phenylephrine, an active ingredient in Sudafed PE, is not effective for its intended use as a nasal decongestant. This decision has led to a proposal to ban the ingredient from over-the-counter products. Phenylephrine is present in various other products such as NyQuil, Benadryl, and Mucinex.

Jason Scheid, director of pharmacy services for community and specialty programs at OSF, commented on the FDA's actions. He mentioned that the agency is currently seeking public comments on this proposal into 2025. Scheid also suggested alternatives for those looking to relieve congestion.

“If you’re looking for an oral decongestant, the original Sudafed is a good alternative,” Scheid noted. “You have to show your ID, and there are purchase limitations. It has shown itself to be an effective alternative. There are nasal decongestants you can try, like Afrin. There are also nasal steroids and antihistamines—this gets more into the allergy nasal sprays that can help prevent congestion symptoms. You can pick any of those up over the counter at a local pharmacy.”

The FDA emphasized that while they propose removing these products from store shelves due to ineffectiveness, there are no safety concerns associated with them. Additionally, Scheid suggested natural remedies such as standing in a hot shower or using a cool mist humidifier as methods to alleviate congestion.

ORGANIZATIONS IN THIS STORY

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

DONATE

Help support the Metric Media Foundation's mission to restore community based news.
Donate

MORE NEWS